Precigen logo

Precigen Share Price (NASDAQ: PGEN)

$4.79

0.2

(4.36%)

Live

Last updated on

Check the interactive Precigen Stock chart to analyse performance

Precigen stock performance

as on August 28, 2025 at 11:39 pm IST

  • Today's Low:$4.59
    Today's High:$4.80

    Day's Volatility :4.38%

  • 52 Weeks Low:$0.65
    52 Weeks High:$4.79

    52 Weeks Volatility :86.4%

Precigen Stock Returns

PeriodPrecigen IncSector (Health Care)Index (Russel 2000)
3 Months
230.22%
4.2%
0.0%
6 Months
162.29%
-8.0%
0.0%
1 Year
306.19%
-12.1%
0.0%
3 Years
90.46%
7.6%
-6.9%

Precigen Inc Key Stats

Check Precigen key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.59
Open
$4.32
Today's High
$4.82
Today's Low
$4.55
Market Capitalization
$1.3B
Today's Volume
$13.3M
52 Week High
$4.8
52 Week Low
$0.6513
Revenue TTM
$4.3M
EBITDA
$-91.9M
Earnings Per Share (EPS)
$-0.41
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-668.03%

Stock Returns calculator for Precigen Stock including INR - Dollar returns

The Precigen stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Precigen investment value today

Current value as on today

₹4,28,253

Returns

₹3,28,253

(+328.25%)

Returns from Precigen Stock

₹3,23,894 (+323.89%)

Dollar Returns*

₹4,360 (+4.36%)

Indian investors sentiment towards Precigen Stock

2100.0%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Investment in Precigen Shares from India has grown by 2100.0% over the past 30 days, indicating increased transactional activity.

2371%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Precigen Stock from India on INDmoney has increased by 2371% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Precigen Inc

  • Name

    Holdings %

  • Patients Capital Management LLC

    5.46%

  • Adage Capital Partners Gp LLC

    3.78%

  • BlackRock Inc

    3.61%

  • Vanguard Group Inc

    3.04%

  • Iridian Asset Management LLC

    1.44%

  • Geode Capital Management, LLC

    1.17%

Analyst Recommendation on Precigen Stock

Rating
Trend

Buy

    81%Buy

    9%Hold

    9%Sell

Based on 11 Wall street analysts offering stock ratings for Precigen(by analysts ranked 0 to 5 stars)

Precigen Share Price Target

What analysts predicted

Upside of 72.23%

Target:

$8.25

Current:

$4.79

Precigen share price target is $8.25, a slight Upside of 72.23% compared to current price of $4.79 as per analysts' prediction.

Precigen Stock Insights

  • Price Movement

    In the last 1 month, PGEN stock has moved up by 190.5%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.34M → 856.0K (in $), with an average decrease of 36.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -54.15M → -26.64M (in $), with an average increase of 103.3% per quarter
  • PGEN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 115.3% return, outperforming this stock by 29.5%

Precigen Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$3.9M
↓ 36.95%
Net Income
$-126.2M
↑ 31.63%
Net Profit Margin
-3.2K%
↓ 1675.55%

Precigen Technicals Summary

Sell

Neutral

Buy

Precigen is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Precigen Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Precigen Inc logo
192.36%
162.29%
306.19%
90.46%
-24.13%
Regeneron Pharmaceuticals, Inc. logo
5.16%
-16.48%
-51.06%
-0.98%
-5.32%
Beone Medicines Ltd logo
-1.83%
7.82%
51.46%
79.4%
24.25%
Vertex Pharmaceuticals Incorporated logo
-16.94%
-18.0%
-20.55%
38.17%
39.4%
Alnylam Pharmaceuticals, Inc. logo
37.4%
91.56%
61.8%
117.28%
242.42%

About Precigen Inc

Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients. It also develops programs based on the UltraCAR-T platform, including PRGN-3005 in Phase 1b clinical trial to treat advanced ovarian, fallopian tube, or primary peritoneal cancer; PRGN-3006 in Phase 1b trial for patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromes; and PRGN-3007 in Phase 1/1b trial for the treatment of advanced receptor tyrosine kinase-like orphan receptor 1-positive, hematologic, and solid tumors. In addition, the company is developing programs based on the AdenoVerse immunotherapy platform comprising PRGN-2009 in Phase 2 trial for patients with HPV+ solid tumors; PRGN-2012 in Phase ½ trial to treat recurrent respiratory papillomatosis; and AG019, which is in Phase 1b/2a trial, to treat type 1 diabetes mellitus. Further, it provides UltraPorator, a proprietary electroporation device; and develops research models and services for healthcare research applications. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in February 2020. Precigen, Inc. was founded in 1998 and is headquartered in Germantown, Maryland.
Organization
Precigen
Employees
143
CEO
Dr. Helen Sabzevari MPH, Ph.D.
Industry
Health Technology

Key Management of Precigen Inc

NameTitle
Mr. Randal J. Kirk J.D.
Executive Chairman
Dr. Helen Sabzevari MPH, Ph.D.
President, CEO & Director
Mr. Harry Thomasian Jr.
Chief Financial Officer
Mr. Rutul R. Shah
Chief Operating Officer
Mr. Donald P. Lehr J.D., Ph.D.
Chief Legal Officer & Corporate Secretary
Mr. Phil Tennant
Chief Commercial Officer
Mr. Steven M. Harasym
VP & Head of Investor Relations
Mr. Rob Russell
VP & Head of Human Resources
Dr. Douglas E. Brough Ph.D.
Senior VP & Head of Research
Dr. Bryan T. Butman Ph.D.
Senior VP & Head of CMC

Important FAQs about investing in PGEN Stock from India :

What is Precigen share price today?

Precigen share price today is $4.79 as on . Precigen share today touched a day high of $4.80 and a low of $4.59.

What is the 52 week high and 52 week low for Precigen share?

Precigen share touched a 52 week high of $4.79 and a 52 week low of $0.65. Precigen stock price today i.e. is trending at $4.79, lower by 0% versus the 52 week high.

How to invest in Precigen Stock (PGEN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Precigen on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Precigen Shares that will get you 0.3132 shares as per Precigen share price of $4.79 per share as on August 28, 2025 at 11:39 pm IST.

What is the minimum amount required to buy Precigen Stock (PGEN) from India?

Indian investors can start investing in Precigen (PGEN) shares with as little as ₹87.587 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.87 in Precigen stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Precigen share’s latest price of $4.79 as on August 28, 2025 at 11:39 pm IST, you will get 2.0877 shares of Precigen. Learn more about fractional shares .

What are the returns that Precigen has given to Indian investors in the last 5 years?

Precigen stock has given -24.13% share price returns and 18.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?